Showing results (1-10 of 4) with videos related to
Sort By:
Pageof 1
Vascular Health and Risk Management|February 27, 2007
Ximelagatran: direct thrombin inhibitorShir-Jing Ho, Tim A BrightonJournal of Thrombosis and Thrombolysis|August 6, 2005
Once-daily enoxaparin in the outpatient setting versus unfractionated heparin in hospital for the treatment of symptomatic deep-vein thrombosisBeng H Chong, Tim A Brighton, Ross I Baker, et al.Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|August 18, 2004
Increased platelet-derived microparticles in the coronary circulation of percutaneous transluminal coronary angioplasty patientsJudy A Craft, Paul P Masci, Michael S Roberts, et al.The Lancet. Haematology|April 1, 2016
Oral rivaroxaban versus enoxaparin with vitamin K antagonist for the treatment of symptomatic venous thromboembolism in patients with cancer (EINSTEIN-DVT and EINSTEIN-PE): a pooled subgroup analysis of two randomised controlled trialsMartin H Prins, Anthonie W A Lensing, Tim A Brighton, et al.Pageof 1